Chimeric Antigen Receptor News and Research

RSS
Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma

Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma

Eliminating key gene could revive exhausted immune cells to battle solid tumors

Eliminating key gene could revive exhausted immune cells to battle solid tumors

Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro

Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro

Study investigates effect of anti-CD45 RIT lymphodepletion on immune cell types

Study investigates effect of anti-CD45 RIT lymphodepletion on immune cell types

MDC researchers develop a potent weapon against lymphomas

MDC researchers develop a potent weapon against lymphomas

NCCN publishes new informational resources on health and wellness for cancer survivors

NCCN publishes new informational resources on health and wellness for cancer survivors

Researchers discover protein crucial to T cell metabolism and anti-tumor immune response

Researchers discover protein crucial to T cell metabolism and anti-tumor immune response

New cell therapy can boost immunotherapy against breast cancer

New cell therapy can boost immunotherapy against breast cancer

Study shows how STAT5 optimizes function of CD4+ T cells to drive antitumor immunity

Study shows how STAT5 optimizes function of CD4+ T cells to drive antitumor immunity

Study finds CAR T cell therapy as effective as first-line treatment for high-risk large B-cell lymphoma

Study finds CAR T cell therapy as effective as first-line treatment for high-risk large B-cell lymphoma

Study: CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

Study: CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

Genetically engineered T cells can  target, attack pathogenic T cells that cause Type 1 diabetes

Genetically engineered T cells can target, attack pathogenic T cells that cause Type 1 diabetes

More than 40 Dana-Farber studies to be presented at the virtual 62nd ASH Annual Meeting

More than 40 Dana-Farber studies to be presented at the virtual 62nd ASH Annual Meeting

Penn study opens the door to let CAR T cells reach the tumor microenvironment

Penn study opens the door to let CAR T cells reach the tumor microenvironment

Combining cell engineering with machine learning to design living medicines for cancer

Combining cell engineering with machine learning to design living medicines for cancer

Novel CAR T-cell therapy shows promising early results in children with neuroblastoma

Novel CAR T-cell therapy shows promising early results in children with neuroblastoma

A new method to improve the preclinical evaluation of CAR T cell therapies

A new method to improve the preclinical evaluation of CAR T cell therapies

Radiation therapy before CART-BCMA appears to be a safe option for multiple myeloma patients

Radiation therapy before CART-BCMA appears to be a safe option for multiple myeloma patients

Novel microfluidic approach to fight cancer could greatly benefit patients

Novel microfluidic approach to fight cancer could greatly benefit patients

A strategic collaboration to speed up the development of allogeneic cell therapies

A strategic collaboration to speed up the development of allogeneic cell therapies